Cargando…
PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429248/ http://dx.doi.org/10.1097/01.HS9.0000975944.73895.05 |
| _version_ | 1785090664026865664 |
|---|---|
| author | Duell, Johannes Abrisqueta, Pau Dreyling, Martin Gaidano, Gianluca Barca, Eva González Jurczak, Wojciech Liberati, Anna Marina Maddocks, Kami Menne, Tobias Nagy, Zsolt Tournilhac, Olivier Bakuli, Abhishek Amin, Aasim Gurbanov, Konstantin Salles, Gilles |
| author_facet | Duell, Johannes Abrisqueta, Pau Dreyling, Martin Gaidano, Gianluca Barca, Eva González Jurczak, Wojciech Liberati, Anna Marina Maddocks, Kami Menne, Tobias Nagy, Zsolt Tournilhac, Olivier Bakuli, Abhishek Amin, Aasim Gurbanov, Konstantin Salles, Gilles |
| author_sort | Duell, Johannes |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429248 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104292482023-08-17 PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA Duell, Johannes Abrisqueta, Pau Dreyling, Martin Gaidano, Gianluca Barca, Eva González Jurczak, Wojciech Liberati, Anna Marina Maddocks, Kami Menne, Tobias Nagy, Zsolt Tournilhac, Olivier Bakuli, Abhishek Amin, Aasim Gurbanov, Konstantin Salles, Gilles Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429248/ http://dx.doi.org/10.1097/01.HS9.0000975944.73895.05 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Duell, Johannes Abrisqueta, Pau Dreyling, Martin Gaidano, Gianluca Barca, Eva González Jurczak, Wojciech Liberati, Anna Marina Maddocks, Kami Menne, Tobias Nagy, Zsolt Tournilhac, Olivier Bakuli, Abhishek Amin, Aasim Gurbanov, Konstantin Salles, Gilles PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title | PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_full | PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_fullStr | PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_full_unstemmed | PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_short | PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA |
| title_sort | pb2304: five-year subgroup analysis of tafasitamab + lenalidomide from the phase ii l-mind study in patients with relapsed or refractory diffuse large b-cell lymphoma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429248/ http://dx.doi.org/10.1097/01.HS9.0000975944.73895.05 |
| work_keys_str_mv | AT duelljohannes pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT abrisquetapau pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT dreylingmartin pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT gaidanogianluca pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT barcaevagonzalez pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT jurczakwojciech pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT liberatiannamarina pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT maddockskami pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT mennetobias pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT nagyzsolt pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT tournilhacolivier pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT bakuliabhishek pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT aminaasim pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT gurbanovkonstantin pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma AT sallesgilles pb2304fiveyearsubgroupanalysisoftafasitamablenalidomidefromthephaseiilmindstudyinpatientswithrelapsedorrefractorydiffuselargebcelllymphoma |